Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 156

Similar articles for PubMed (Select 23864169)

1.

GUEPARD treat-to-target strategy is significantly more efficacious than ESPOIR routine care in early rheumatoid arthritis according to patient-reported outcomes and physician global estimate.

Castrejón I, Pincus T, Soubrier M, Lin YC, Rat AC, Combe B, Dougados M.

Rheumatology (Oxford). 2013 Oct;52(10):1890-7. doi: 10.1093/rheumatology/ket230. Epub 2013 Jul 17.

2.

Can remission in rheumatoid arthritis be assessed without laboratory tests or a formal joint count? possible remission criteria based on a self-report RAPID3 score and careful joint examination in the ESPOIR cohort.

Castrejón I, Dougados M, Combe B, Guillemin F, Fautrel B, Pincus T.

J Rheumatol. 2013 Apr;40(4):386-93. doi: 10.3899/jrheum.121059. Epub 2013 Feb 1.

PMID:
23378463
4.

Evaluation of disease activity in rheumatoid arthritis by Routine Assessment of Patient Index Data 3 (RAPID3) and its correlation to Disease Activity Score 28 (DAS28) and Clinical Disease Activity Index (CDAI): an Indian experience.

Singh H, Gupta V, Ray S, Kumar H, Talapatra P, Kaur M, Kumar S, Arya S, Mathur R, Ghangas N.

Clin Rheumatol. 2012 Dec;31(12):1663-9. doi: 10.1007/s10067-012-2070-9. Epub 2012 Sep 15.

PMID:
22983768
5.
8.

Proposed severity and response criteria for Routine Assessment of Patient Index Data (RAPID3): results for categories of disease activity and response criteria in abatacept clinical trials.

Pincus T, Hines P, Bergman MJ, Yazici Y, Rosenblatt LC, MacLean R.

J Rheumatol. 2011 Dec;38(12):2565-71. doi: 10.3899/jrheum.110262. Epub 2011 Nov 15.

PMID:
22089467
9.
10.

Disease activity score-driven therapy versus routine care in patients with recent-onset active rheumatoid arthritis: data from the GUEPARD trial and ESPOIR cohort.

Soubrier M, Lukas C, Sibilia J, Fautrel B, Roux F, Gossec L, Patternotte S, Dougados M.

Ann Rheum Dis. 2011 Apr;70(4):611-5. doi: 10.1136/ard.2010.137695. Epub 2011 Jan 17.

11.

The comparative responsiveness of the patient self-report questionnaires and composite disease indices for assessing rheumatoid arthritis activity in routine care.

Salaffi F, Ciapetti A, Gasparini S, Carotti M, Bombardieri S; New Indices study group.

Clin Exp Rheumatol. 2012 Nov-Dec;30(6):912-21. Epub 2012 Dec 17.

PMID:
22935335
12.

RAPID3, an index to assess and monitor patients with rheumatoid arthritis, without formal joint counts: similar results to DAS28 and CDAI in clinical trials and clinical care.

Pincus T, Yazici Y, Bergman MJ.

Rheum Dis Clin North Am. 2009 Nov;35(4):773-8, viii. doi: 10.1016/j.rdc.2009.10.008. Review.

PMID:
19962621
13.

Patient self-report outcomes to guide a treat-to-target strategy in clinical trials and usual clinical care of rheumatoid arthritis.

Castrejón I, Pincus T.

Clin Exp Rheumatol. 2012 Jul-Aug;30(4 Suppl 73):S50-5. Epub 2012 Oct 16. Review.

PMID:
23079199
15.

Evaluation of self-report questionnaires for assessing rheumatoid arthritis activity: a cross-sectional study of RAPID3 and RADAI5 and flare detection in 200 patients.

Bossert M, Prati C, Vidal C, Bongain S, Toussirot E, Wendling D.

Joint Bone Spine. 2012 Jan;79(1):57-62. doi: 10.1016/j.jbspin.2011.03.014. Epub 2011 May 6.

PMID:
21550283
18.

Test-retest reliability of disease activity core set measures and indices in rheumatoid arthritis.

Uhlig T, Kvien TK, Pincus T.

Ann Rheum Dis. 2009 Jun;68(6):972-5. doi: 10.1136/ard.2008.097345. Epub 2008 Oct 28.

PMID:
18957489
19.
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk